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a b s t r a c t
Neural crest cells are an embryonic cell population that is crucial for proper vertebrate development.
Initially localized to the dorsal neural folds, premigratory neural crest cells undergo an epithelial-to-
mesenchymal transition (EMT) and migrate to their ﬁnal destinations in the developing embryo.
Together with epidermally-derived placode cells, neural crest cells then form the cranial sensory ganglia
of the peripheral nervous system. Our prior work has shown that αN-catenin, the neural subtype of the
adherens junction α-catenin protein, regulates cranial neural crest cell EMT by controlling premigratory
neural crest cell cadherin levels. Although αN-catenin down-regulation is critical for initial neural crest
cell EMT, a potential role for αN-catenin in later neural crest cell migration, and formation of the cranial
ganglia, has not been examined. In this study, we show for the ﬁrst time that migratory neural crest cells
that will give rise to the cranial trigeminal ganglia express αN-catenin and Cadherin-7. αN-catenin loss-
and gain-of-function experiments reveal effects on the migratory neural crest cell population that
include subsequent defects in trigeminal ganglia assembly. Moreover, αN-catenin perturbation in neural
crest cells impacts the placode cell contribution to the trigeminal ganglia and also changes neural crest
cell Cadherin-7 levels and localization. Together, these results highlight a novel function for αN-catenin
in migratory neural crest cells that form the trigeminal ganglia.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Consisting of neuronal and glial cells within the sensory
component of the trigeminal (V), facial (VII), glossopharyngeal
(IX), and vagal (X) cranial nerves, cranial ganglia collectively
mediate several critical functions, including somatosensation
(temperature, pain, touch), taste, and the visceral sensation of
internal organs such as the heart, lungs and gastrointestinal tract.
The intermingling and coalescing of two distinct cell populations,
neural crest cells and placode cells, is required for the formation of
these cranial ganglia (Blentic et al., 2011; D’Amico-Martel, 1982;
D’Amico-Martel and Noden, 1983; Hamburger, 1961; Jidigam and
Gunhaga, 2013; Saint-Jeannet and Moody, 2014; Shiau et al., 2008;
Steventon et al., 2014; Theveneau et al., 2013). Neural crest cells
are multi-potent cells that give rise to a variety of cell types in the
developing vertebrate embryo. Upon reaching their destination,
cranial neural crest cells will differentiate into structures such as
the craniofacial skeleton and sensory ganglia of the peripheral
nervous system, dependent upon molecular cues received from
the surrounding tissue and their axial level of origin (Mayor and
Theveneau, 2013; Sauka-Spengler and Bronner, 2010). Epidermal
placode cells arise at the border of the developing neural plate in
distinct rostro-caudal positions. These paired localized ectodermal
thickenings in the vertebrate head give rise to cranial sense
organs, such as the ear and nose, and contribute to the cranial
sensory nerves (Jidigam and Gunhaga, 2013; Saint-Jeannet and
Moody, 2014; Steventon et al., 2014). Importantly, neural crest
cells are thought to provide the scaffolding with which placode
cells interact to form the cranial ganglia, while placode cells
facilitate neural crest cell coalescence (Shiau et al., 2008). Not
surprisingly, the proper intermixing of neural crest cells and
placode cells to create the cranial ganglia relies on complex
molecular interactions in which neural crest cells, through a
“chase and run” mechanism involving Sdf1 and planar cell polarity
and N-cadherin signaling, generate “corridors” upon which pla-
code cells migrate (Freter et al., 2013; Theveneau et al., 2013).
Other known molecules that function during ganglia formation
include N-cadherin in placode cells (Shiau and Bronner-Fraser,
2009), Neuropilin 2/Semaphorin 3F signaling in neural crest cells
(Gammill et al., 2007), and Slit1/Robo2 signaling between neural
crest cells and placode cells (Shiau et al., 2008). Given these
ﬁndings, it is likely that adherens junctions play an important
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role in mediating neural crest cell and placode cell interactions to
form the ganglia, but their components in cranial neural crest cells
have yet to be identiﬁed.
αN-catenin is a critical mediator of cadherin function as part of
the apically-localized adherens junctions and promotes the crea-
tion of multi-cellular structures (Hirano et al., 1992; Watabe et al.,
1994). Our prior work deﬁned a function for αN-catenin in cranial
neural crest cell EMT, with αN-catenin down-regulation occurring
during neural crest cell EMT and in early emigrating neural crest
cells (Jhingory et al., 2010). Moreover, αN-catenin depletion or
overexpression enhances or inhibits neural crest cell EMT/migra-
tion, respectively, in part due to loss or maintenance of premi-
gratory neural crest cell cadherins. In chick and mouse, αN-catenin
is expressed in a tissue-speciﬁc manner, most highly in central and
peripheral nervous system structures (Uchida et al., 1994; Uemura
and Takeichi, 2006). αN-catenin knock-out mice possess aberrant
axon pathﬁnding and cranial ganglia morphology (Park et al.,
2002a) as well as abnormal localization of Purkinje cells, which
form loosened adhesions with their targets (Park et al., 2002b;
Shimoyama et al., 1992). As such, it is likely that αN-catenin plays a
later role in the development of neural crest-derived structures
such as the cranial ganglia.
One of the best-characterized cranial ganglia is the trigeminal
ganglia due to their large size and accessibility. The proximal
regions of these ganglia, as well as all glial cells that envelop their
axons, are of neural crest cell origin, while the placodes contribute
to more distal portions (D’Amico-Martel and Noden, 1983;
Hamburger, 1961). Using the chick trigeminal ganglia as a model,
we investigated whether αN-catenin plays a role in neural crest
cells during their migration and intermixing with placode cells to
form the trigeminal ganglia. Our results reveal that αN-catenin
is expressed by Cadherin-7-positive migratory neural crest cells,
and that αN-catenin levels in neural crest cells must be tightly
regulated in order to generate proper trigeminal ganglia morphol-
ogy. Both αN-catenin depletion and overexpression in neural crest
cells disrupts this process, leading to quantitative changes in the
migratory neural crest cell domain that will give rise to the
trigeminal ganglion and subsequent effects on ganglion assembly.
Furthermore, αN-catenin perturbation in neural crest cells leads to
changes in the number or distribution of placode cells contributing
to the ganglion and alters levels of neural crest cell Cadherin-7.
Given the requirement for neural crest cells to associate with
placode cells to form cranial ganglia, our results on αN-catenin
may be translatable to the formation of other cranial ganglia.
Collectively, our data highlight a novel role for αN-catenin in
migratory neural crest cells that interact with placode cells to form
the trigeminal ganglia.
Results
αN-catenin is expressed by Cadherin-7-positive migratory neural
crest cells
To determine whether αN-catenin plays a role in migratory
neural crest cells that will form peripheral nervous system structures
such as the trigeminal ganglia, we sought to identify the distribution
of it, along with any cadherins with which it might indirectly interact,
through immunohistochemistry (Jhingory et al., 2010; Nakagawa and
Takeichi, 1998). In the developing trigeminal ganglia, we note that
Cadherin-7 protein is present in migratory cranial neural crest cells,
as observed in the chick trunk (Nakagawa and Takeichi, 1998) and
conﬁrmed by co-staining for the migratory neural crest cell marker
HNK-1 (Figs. 1A,A0, arrowheads), while Islet-1-positive placode cells
express N-cadherin on the cell surface and cytosol (Figs. 1B,B0,
arrowhead and caret, respectively; (Shiau and Bronner-Fraser,
2009)). Importantly, Cadherin-7-positive migratory neural crest cells
forming the trigeminal ganglion express αN-catenin (Figs. 1C,C0,
arrowhead and caret), which is observed on the membrane
(Fig. 1C0, arrowhead) and in the cytosol (Fig. 1C0, caret). Finally,
Cadherin-7-positive neural crest cells intermingle and condense with
N-cadherin-positive placode cells during trigeminal ganglia assem-
bly, with membranes of both cell types close apposed (Figs. 1D,D0,
arrowheads). These results indicate that αN-catenin is in fact
expressed in later Cadherin-7-positive migratory neural crest cells
in the proper time and place to play a role neural crest cells as they
coalesce with placode cells to form the trigeminal ganglia.
αN-catenin depletion expands the migratory neural crest cell domain
and disrupts trigeminal ganglia morphology
Using reagents we developed previously (Jhingory et al., 2010),
we depleted αN-catenin from premigratory cranial neural crest
cells just prior to their emergence from the dorsal neural tube
(HH9) using a morpholino (MO), or a 5 bp mismatch control MO,
and incubated embryos to Hamburger–Hamilton stage (HH) 14–17
in order to examine effects on the neural crest cell population and
the forming trigeminal ganglia. Whole-mount in situ hybridization
for Sox10 after αN-catenin depletion reveals an increase in the
migratory neural crest cell domain contributing to the trigeminal
ganglion on the treated side of the embryo (Fig. 2A, arrow; 10/10
embryos), compared to the contralateral side (Fig. 2B) and to
control MO-treated embryos (Figs. 2C,D; 9/10 embryos), at all
stages examined. In these treated embryos, more neural crest cells
appear to move anteriorly to the ocular region upon αN-catenin
knock-down (Fig. 2A; asterisk shows cells from A that are also
apparent in B due to transparency of embryo). Serial sections
through the forming trigeminal ganglia corroborate this and show
that αN-catenin depletion expands the Sox10-positive migratory
neural crest cell domain along the dorsal–ventral axis (Figs. 2E,F,
arrows and lines; left side of section), compared to control MO-
treated embryos (Fig. 2G), and consistent with our prior studies
(Jhingory et al., 2010). Quantiﬁcation of this phenotype by measur-
ing the migrated distance along the dorsal–ventral domain length
(indicated by the lines in (E,F)) through serial sections reveals a
slight increase upon αN-catenin depletion (average length of the
αN-catenin MO side: 550728; average length of the contralateral
side: 459725; 1.2-fold difference, p¼0.019; Supp. Table 1).
We next examined migratory neural crest cells by performing
HNK-1 immunohistochemistry (Fig. 3). In keeping with the Sox10
data, the trigeminal ganglion on the αN-catenin MO-treated side
appeared larger than that observed on the contralateral side
(compare left (where MO-positive cells are present) and right
sides of Fig. 3A; higher magniﬁcation image indicated by arrow is
shown in A0; 7/7 embryos) and in control MO-treated embryos
(Fig. 3B, left side; B0 is higher magniﬁcation image indicated by
arrow; 7/8 embryos). To quantify this difference, we manually
outlined the region occupied by HNK-1-positive neural crest cells
forming the trigeminal ganglia, on both the experimental and
contralateral control sides of serial sections, after MO-mediated
knock-down of αN-catenin, and then calculated the area (Adobe
Photoshop; see Supp. Table 2 for measurements). In younger
embryos (HH13-14), we ﬁnd a statistically signiﬁcant increase in
the area occupied by migratory neural crest cells contributing to
the trigeminal ganglion upon αN-catenin depletion (αN-catenin
MO side: 54,19374340; contralateral side: 35,65573626; 1.5-
fold, p¼0.0025). Embryos at slightly later stages (HH15-17) also
reveal a statistically signiﬁcant increase (αN-catenin MO side:
214,359715928; contralateral side: 163,524716682; 1.3-fold,
p¼0.032). These results demonstrate that the size of the migratory
neural crest cell domain is affected upon αN-catenin depletion,
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Fig. 1. Migratory neural crest cells contributing to the trigeminal ganglia express Cadherin-7 and αN-catenin and closely intermingle with N-cadherin-positive placode cells.
Representative transverse sections taken through a forming trigeminal ganglion in different HH14 (A,C,D) or HH16 (C) embryos following co-immunohistochemistry for
(A) Cadherin-7 (Cad7, green) and HNK-1 (red); (B) N-cadherin (N-cad, green) and Islet-1 (purple); (C) αN-catenin (αN-cat, green) and Cad7 (red); and (D) Cadherin-7 (green)
and N-cad (red). (A0–D0) Higher magniﬁcation of region indicated by the arrow in (A–D). Arrowheads in (A0 ,C0) reveal co-localization of Cadherin-7 and HNK-1, or αN-catenin
and Cadherin-7, at the plasma membrane, or (B0) the presence of N-cadherin on the plasma membrane, while arrowheads in (D0) point to closely apposed Cadherin-7-
positive migratory neural crest cell and N-cadherin-positive placode cell plasma membranes. Asterisks (n) in (B,D) indicate N-cadherin protein in the surface ectoderm, while
carets (\widehat) in (B0 ,C0) point to cytosolic N-cadherin and αN-catenin protein distribution, respectively. DAPI (blue) labels cell nuclei. EE, embryonic ectoderm; NT, neural
tube; TG, trigeminal ganglion. Scale bars in (A) and (A0) are 20 mm and 8 mm, respectively, and are applicable to respective images.
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which could then potentially impact later trigeminal ganglia
assembly.
Migratory neural crest cells must coalesce with placode cells to
form the cranial ganglia. As such, it is possible that perturbing
molecules in neural crest cells could alter neural crest cell–placode
cell interactions and therefore adversely impact ganglia formation.
To evaluate gross effects on trigeminal ganglion morphology and
give insight to potential effects on placode cell-derived neuronal
contributions to the ganglia after αN-catenin knock-down, we
performed whole-mount immunohistochemistry for Tubb3 (TuJ1
antibody). Because neural crest-derived neurons do not exit the
cell cycle and differentiate into neurons until much later than the
stages we are examining (HH19þ), any neurons that are found in
the trigeminal ganglion prior to this that are positive for Tubb3
should be placode-derived (Begbie et al., 2002; Blentic et al., 2011;
D’Amico-Martel, 1982; D’Amico-Martel and Noden, 1980, 1983;
Shiau et al., 2008; Shiau and Bronner-Fraser, 2009). Upon αN-
catenin depletion in neural crest cells (noted by the MO-positive
cells in the ganglion-forming region), placode-derived neurons
within the ganglion were altered in appearance (Fig. 4A; 14/15
embryos), compared to the contralateral side (Fig. 4B) and to control
MO-treated embryos (Figs. 4C,D; 10/12 embryos). In general,
Tubb3-positive neurons appear less condensed (Fig. 4A, arrows)
and do not extend as far anteriorly towards the eye. Moreover,
Fig. 2. Morpholino-mediated depletion of αN-catenin expands the dorsal–ventral domain of migratory neural crest cells forming the trigeminal ganglion in vivo. (A,B)
Representative image of a lateral view of an embryo head following whole-mount in situ hybridization for Sox10 after electroporation with αN-catenin MO and re-incubation
to HH15. (A) MO-treated and (B) contralateral sides. Inset image in (A) shows red ﬂuorescence of the electroporated MO on the left side of the neural tube that is not visible
after in situ hybridization at this later stage. Arrow in (A) indicates an increased Sox10-positive migratory neural crest cell domain on the MO-treated side that is not observed
on the contralateral side (B) of the same embryo. Asterisk (n) in (A,B) points to neural crest cells entering the ocular region on the MO-treated side that are observed on the
contralateral control side due to the transparency of the embryo. (C,D) Representative image of a lateral view of an embryo head following whole-mount in situ hybridization
for Sox10 after electroporation with αN-catenin control MO (control MO) and re-incubation to HH15. (C) MO-treated and (D) contralateral sides. Inset image in (C) shows red
ﬂuorescence of the electroporated MO on the left side of the neural tube that is not visible after in situ hybridization at this later stage. (E–G) Representative transverse
sections taken at the axial level of the developing trigeminal ganglia after αN-catenin (E,F) or control (G) MO electroporation, re-incubation of the embryo to HH14 (E) or
HH15 (F,G), and Sox10 whole-mount in situ hybridization. Arrows and lines in (E,F) reveal a dorsal–ventral expansion of the migratory neural crest cell domain on the
electroporated side of the embryo (left) compared to the contralateral side of the same section (right), with no change in domain size observed in the control (G). e, eye; TG,
trigeminal ganglion. Scale bars in all images are 100 mm, with scale bar in (A) applicable to (B–D) and scale bar in (F) applicable to (G).
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immunohistochemistry for Islet-1 reveals that placode cells are
qualitatively more spread out (Fig. 4E, arrow; 11/11 embryos),
compared to the control side of the treated embryo (Fig. 4F) and
to control MO-treated embryos (Figs. 4G,H, arrow; 3/3 embryos).
Although the total number of Islet-1-positive placode cells was not
signiﬁcantly different when compared to the contralateral side of
the same embryo (αN-catenin MO side: 8575; contralateral side:
8676; p¼0.99), there was a reduction in the number of placode
cells per given measured area within the trigeminal ganglion (αN-
catenin MO side: 2772; contralateral side: 3673; 1.3-fold
decrease; p¼0.033; 8 embryos examined). These results suggest
that placode cells are more dispersed within the forming trigeminal
ganglion upon αN-catenin knock-down.
To rule out any non-speciﬁc effects that might lead to these
phenotypes, we analyzed αN-catenin or control MO-treated
embryos for effects on cell proliferation (phospho-histone H3
immunohistochemistry) and cell death (TUNEL) in serial sections
through the developing trigeminal ganglia (Supp. Fig. 1), as in our
prior work (Jhingory et al., 2010). We observe no change in
phospho-histone H3 immunostaining between the experimental
and contralateral sides of control MO- (Supp. Figs. 1A,B,
arrowheads; control MO side: 1271 cell, contralateral side:
1271 cell; 5/5 embryos) and αN-catenin MO-treated (Supp.
Figs. 1C,D, arrowheads; αN-catenin MO side: 1372 cells, contral-
ateral side: 1271 cell; 5/6 embryos) embryo sections. Further-
more, we note no difference in cell death after either MO
treatment (Supp. Figs. 1E,F, arrowheads; control MO side: 1972
cells; contralateral side: 1972 cells, 5/5 embryos; Supp. Figs. 1G,H,
arrowheads; αN-catenin MO side: 1171 cell; contralateral side:
1271 cell; 6/7 embryos). Collectively, these results indicate that
abnormalities in trigeminal ganglion assembly upon αN-catenin
knock-down are not due to alterations in cell proliferation or death
but are instead likely due to effects on the migratory neural crest
cell population that subsequently intermingles with placode cells
to form the trigeminal ganglia.
αN-catenin overexpression reduces the size of the migratory neural
crest cell domain and alters trigeminal ganglia assembly
To conﬁrm our knock-down results, we overexpressed αN-
catenin in neural crest cells just prior to their emergence from the
dorsal neural tube (HH9) using the pCIG-αN-catenin construct we
Fig. 3. Morpholino-mediated depletion of αN-catenin increases the migratory neural crest cell contribution to the forming trigeminal ganglion in vivo. (A,B) Representative
transverse sections taken at the axial level of the forming trigeminal ganglia of an HH15þ (A,A0) and HH15 (B,B0) embryo following αN-catenin (A) or control (B) MO (red)
electroporation earlier in development and HNK-1 (green) immunohistochemistry after re-incubation. Arrows in (A,B) point to the region shown at higher magniﬁcation in
(A0 ,B0). DAPI (blue) labels cell nuclei in all images. Asterisk (n) in (A,B) indicates blood cells. EE, embryonic ectoderm; NT, neural tube; TG, trigeminal ganglion. Scale bars in
(A) and (A0) are 100 and 50 mm, respectively, and applicable to (B) and (B0).
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generated previously, which contains an IRES-GFP to label electro-
porated cells (Jhingory et al., 2010). Because it takes approximately
6 h to express αN-catenin from the plasmid (our observations; see
also (Jhingory et al., 2010)), we can target αN-catenin in neural
crest cells at later stages during their migration (HH10 and
beyond). Detection of migratory neural crest cells through Sox10
whole-mount in situ hybridization indicates changes in neural
crest cells contributing to the trigeminal ganglion (Figs. 5A, 9/10
embryos), compared to the contralateral side (Fig. 5B) and in pCIG
control-treated embryos (Figs. 5C,D; 8/9 embryos). Although
neural crest cells are observed in the ganglion-forming region,
we observe a general decrease in Sox10, indicating a potential
reduction in neural crest cells in this region (Fig. 5A, arrow). We
also note aggregates of neural crest cells within and outside of the
ganglion-forming region (Fig. 5A, arrowheads). These phenotypes
are consistent with what we have observed previously (Jhingory et
al., 2010). In keeping with our observations, serial sections through
the forming trigeminal ganglion show a decreased Sox10-positive
migratory neural crest cell domain (Figs. 5E,F, arrows and lines;
left side of section), compared to pCIG-treated embryos (Fig. 5G).
Quantiﬁcation of this phenotype reveals that the dorsal–ventral
domain length of migratory neural crest cells is greater on the
contralateral side compared to the side in which αN-catenin has
been overexpressed (average length of the contralateral side:
687745; average length of the pCIG-αN-catenin-treated side:
522752; 1.3-fold difference, p¼0.020; Supp. Table 3). These
Fig. 4. Morpholino-mediated depletion of αN-catenin in cranial neural crest cells impacts the formation of placode-derived neurons and the distribution of placode cells
during trigeminal ganglion assembly. (A–D) Representative images of a lateral view of two HH16 embryo heads following whole-mount immunohistochemistry for Tubb3
(green) after unilateral electroporation earlier in development with the αN-catenin (A) or control (C) MO (red) and re-incubation. (B,D) Contralateral sides of respective
embryos. Arrows in (A) point to defects in ganglion assembly (truncated and more dispersed axons) on the MO-treated side that is not observed on the contralateral side of
the same embryo (B) or in control MO-treated embryos (C,D). (E–H) Representative transverse sections taken at the axial level of the forming trigeminal ganglia of two HH14
embryos following αN-catenin (E) or control (G) MO electroporation (both red) of neural crest cells earlier in development, re-incubation, and Islet-1 (purple)
immunohistochemistry. (F,H) Contralateral sides of (E,G), respectively, at the same axial level. Arrow in (E) reveals more dispersed placode cells on the MO-treated side
compared to the contralateral side (F) of the same section and to a section from a control MO-treated embryo (G,H, arrow). DAPI (blue) labels cell nuclei in (E–H). Asterisk (n)
in (E,G,H) indicates blood cells. e, eye; EE, embryonic ectoderm; NT, neural tube; TG, trigeminal ganglion. Scale bar in (A) is 100 mm and applicable to (B-D). Scale bar in (E) is
50 mm and applicable to (F–H).
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results suggest that the size of the migratory neural crest cell
domain is affected upon αN-catenin overexpression, which could
lead to later effects on trigeminal ganglia assembly.
Immunostaining for HNK-1 was also performed on treated
embryos to examine the contribution of migratory neural crest
cells to the ganglion. These experiments revealed the formation of
a generally smaller ganglion upon αN-catenin overexpression
compared to the contralateral side (Fig. 6A, compare left (contain-
ing GFP-positive cells) and right sides of section; A0 is higher
magniﬁcation of ganglion-forming region indicated by arrow; 8/8
embryos). This effect was not observed in pCIG-treated embryos
(Fig. 6B; B0 is higher magniﬁcation of region indicated by arrow;
11/13 embryos). To quantify this phenotype, we carried out a
similar area analysis as conducted for our MO data (Supp. Table 4).
In younger embryos (HH13-14), we ﬁnd that αN-catenin over-
expression reduces the area occupied by neural crest cells con-
tributing to the trigeminal ganglion (pCIG-αN-catenin side:
31,59472448; contralateral side: 47,47473626; 1.5-fold
decrease, p¼0.0027). In older embryos (HH15-17) the effects are
also present (pCIG-αN-catenin side: 158,375710730; contralat-
eral side: 199,627713210; 1.3-fold decrease; p¼0.019). These
results corroborate our MO knock-down data and demonstrate
quantitative differences in the neural crest cell population occupy-
ing the trigeminal ganglion upon αN-catenin perturbation.
Fig. 5. Overexpression of αN-catenin reduces the dorsal–ventral domain of migratory neural crest cells forming the trigeminal ganglion in vivo. (A,B) Representative image of
a lateral view of an embryo head following whole-mount in situ hybridization for Sox10 after electroporation with the pCIG-αN-catenin expression construct and re-
incubation to HH16. (A) Expression construct-treated and (B) contralateral side. Inset image in (A) shows GFP ﬂuorescence of the electroporated expression construct on the
left side of the neural tube that is not visible after in situ hybridization at this later stage. Arrow in (A) indicates a reduction in neural crest cells where they are normally
apparent on the contralateral side (B) of the same embryo. Arrowheads in (A) point to Sox10-positive migratory neural crest cell aggregates. Asterisk (n) in (A,B) labels neural
crest cells on the contralateral side of the embryo that are apparent due to the transparent nature of the embryo. (C,D) Representative image of a lateral view of an embryo
head following whole-mount in situ hybridization for Sox10 after electroporation with the pCIG expression construct and re-incubation to HH15. (C) Expression construct-
treated and (D) contralateral side. Inset image in (C) shows GFP ﬂuorescence of the electroporated construct on the left side of the neural tube that is not visible after in situ
hybridization at this later stage. (E–G) Representative transverse sections taken at the axial level of the developing trigeminal ganglia after pCIG-αN-catenin (E,F) or pCIG
(G) expression construct electroporation, re-incubation of the embryo to HH16 (E,F) or HH14 (G), and Sox10 whole-mount in situ hybridization. Arrows and lines in (E,F)
reveal a dorsal–ventral reduction of the migratory neural crest cell domain on the electroporated side of the embryo (left) compared to the contralateral side of the same
section (right), with no change in domain size observed in the control (G). e, eye; TG, trigeminal ganglion. Scale bars in all images are 100 mm, with scale bar in (A) applicable
to (B–D) and scale bar in (E) applicable to (G).
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We next assessed trigeminal ganglia morphology, and speciﬁ-
cally placode cell contributions, using immunostaining for Tubb3
after αN-catenin overexpression in neural crest cells. Our data
reveal effects on the trigeminal ganglion upon αN-catenin over-
expression (Fig. 7A, note GFP-positive cells within the ganglion-
forming region; 11/13 embryos) compared to the contralateral side
(Fig. 7B) and to pCIG-treated embryos (Figs. 7C,D; 6/7 embryos).
αN-catenin overexpression leads to the presence of disorganized
placode-derived neurons that are not well condensed (Fig. 7A,
arrows). Immunostaining for Islet-1 was then used to further
explore the possibility that αN-catenin overexpression in neural
crest cells can inﬂuence placode cells contributing to the trigem-
inal ganglia. We note a decrease in the number of Islet-1-positive
cells upon αN-catenin overexpression (Fig. 7E, arrow; 11/12
embryos), compared to the contralateral side (Fig. 7F) and to
pCIG-treated embryos (Fig. 7G,H, arrow; 8/8 embryos). To quantify
this observation, we counted the total number of Islet-1-positive
placode cells on each side of the embryo in serial sections. We note
a statistically signiﬁcant 1.4-fold decrease in the number of
placode cells in the forming trigeminal ganglion upon αN-
catenin overexpression in neural crest cells, compared to the
contralateral side of the section (pCIG-αN-catenin side: 3573
cells; contralateral side: 4974 cells; 1.4-fold change; p¼0.0055).
Finally, similar to our αN-catenin depletion experiments, we
observe no change in cell proliferation (Supp. Figs. 2A–D, arrow-
heads; pCIG side: 2371 cell, contralateral side: 2371 cell, 6/6
embryos; pCIG-αN-catenin side: 1171 cell, contralateral side:
1271 cell; 5/5 embryos) or cell death (Supp. Figs. 2E–H, arrow-
heads; pCIG side: 2272 cells, contralateral side: 1972 cells,
6/6 embryos; pCIG-αN-catenin side: 4077 cells, contralateral
side: 4178 cells; 5/6 embryos). These results indicate that neural
crest cell αN-catenin overexpression can inﬂuence placode cell
contribution to the forming trigeminal ganglion, thereby providing
a possible mechanism behind the inappropriate assembly of this
ganglion.
αN-catenin perturbation alters Cadherin-7 distribution and levels in
migratory neural crest cells forming the trigeminal ganglia
Given the observed effects on the trigeminal ganglion upon
αN-catenin perturbation in neural crest cells, we hypothesized
that the neural crest cell adhesion molecule Cadherin-7 was
Fig. 6. αN-catenin overexpression decreases the migratory neural crest cell contribution to the forming trigeminal ganglion in vivo. (A,B) Representative transverse sections
taken at the axial level of the forming trigeminal ganglia of an HH15 (A,A0) and HH14 (B,B0) embryo following pCIG-αN-catenin (A) or pCIG (B) (both green) electroporation
earlier in development and HNK-1 (red) immunohistochemistry after re-incubation. Arrows in (A,B) point to the region shown at higher magniﬁcation in (A0 ,B0). DAPI (blue)
labels cell nuclei in all images. Asterisk (n) in (A) indicates blood cells. EE, embryonic ectoderm; NT, neural tube; TG, trigeminal ganglion. Scale bars in (A) and (A0) are 100 and
50 mm, respectively, and applicable to (B) and (B0).
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altered during ganglion assembly. To address this, we perturbed
αN-catenin via MO or overexpression and assessed effects on
Cadherin-7 within neural crest cells forming the trigeminal gang-
lion through immunohistochemistry. αN-catenin depletion leads
to a general decrease in Cadherin-7 levels, with reduced plasma
membrane localization in neural crest cells (Fig. 8A; arrows point
to respective MO-positive (A0) and MO-negative (A″) regions in
higher magniﬁcation images; arrowheads indicate Cadherin-7 in
neural crest cells). We then quantiﬁed the ﬂuorescence intensity of
Cadherin-7 as in (Wu et al., 2011) to detect differences in regions
containing MO-positive and MO-negative cells (Supp. Table 5).
We note that αN-catenin depletion leads to a 2.2-fold decrease
in Cadherin-7 (average ﬂuorescence intensity/area in αN-cat-
enin MO-positive cells: 0.019270.00283; average ﬂuorescence
intensity/area in αN-catenin MO-negative cells: 0.04267
0.00442; p¼3.8105). Conversely, αN-catenin overexpression
causes Cadherin-7 to become localized in large clusters/puncta on
neural crest cell plasma membranes (Fig. 8B; arrows point to
respective GFP-positive (B0) and GFP-negative (B″) regions in
higher magniﬁcation images; arrowheads indicate Cadherin-7 in
neural crest cells). Cadherin-7 ﬂuorescence intensity measure-
ments reveal a 1.2-fold increase in Cadherin-7 levels (average
ﬂuorescence intensity/area in pCIG-αN-catenin-positive cells:
0.023770.00169; average ﬂuorescence intensity/area in pCIG-
αN-catenin-negative cells: 0.019170.00118; p¼0.029). These data
indicate that αN-catenin perturbation affects Cadherin-7 distribu-
tion and levels in neural crest cells that associate with placode
cells to generate the trigeminal ganglia.
Fig. 7. αN-catenin overexpression within cranial neural crest cells inﬂuences the formation of placode-derived neurons and reduces the number of placode cells during
trigeminal ganglion assembly. (A–D) Representative images of a lateral view of two HH16 embryo heads following whole-mount immunohistochemistry for Tubb3 (red) after
unilateral electroporation earlier in development with pCIG-αN-catenin (A) or pCIG (C) (both green) and re-incubation. (B,D) Contralateral sides of respective embryos.
Arrows in (A) point to aberrant organization and/or dispersal of placode-derived neurons on the pCIG-αN-catenin-treated side that is not observed on the contralateral side
of the same embryo (B) or in pCIG-treated embryos (C,D). (E–H) Representative transverse sections taken at the axial level of the forming trigeminal ganglia of an HH17 (E,F)
and an HH16 (G,H) embryo following pCIG-αN-catenin (E) or pCIG (G) electroporation (both green) earlier in development, re-incubation, and Islet-1 (purple)
immunohistochemistry. (F,H) Contralateral sides of (E,G), respectively, at the same axial level. Arrow in (E) reveals fewer placode cells on the pCIG-αN-catenin-treated
side compared to the contralateral side (F) of the same section and to a section from a pCIG-treated embryo (G,H, arrow). DAPI (blue) labels cell nuclei in (E–H). e, eye; EE,
embryonic ectoderm; NT, neural tube; TG, trigeminal ganglion. Scale bar in (A) is 100 mm and applicable to (B–D). Scale bar in (E) is 50 mm and applicable to (F–H).
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Discussion
αN-catenin possesses multiple functions in neural crest cell ontogeny
As critical components of adherens junctions and mediators
of cellular movement through actin binding, α-catenins possess
unique roles during development. Chick premigratory neural crest
cells express αN-catenin within apical adherens junctions, which
serve to hold these cells in place within the neuroepithelium prior
to receiving cues to initiate EMT and emigrate away from the
dorsal neural tube. During EMT, αN-catenin levels decrease in
premigratory and newly emigratory/migratory cranial neural crest
cells (Jhingory et al., 2010). In the mouse, αN-catenin is observed
in structures of the central and peripheral nervous systems
(Hirano and Takeichi, 1994; Park et al., 2002a, 2002b; Shibuya et
al., 2003; Uemura and Takeichi, 2006). Given a known function for
mouse αN-catenin in the formation of these later nervous system
derivatives (including the trigeminal ganglia; see (Uemura and
Takeichi, 2006)), and for α-catenins in general in facilitating cell
adhesion and migration (Maiden and Hardin, 2011), we reasoned
that it was likely that neural crest cells expressed αN-catenin at
some point later in their migration. To this end, we examined
migratory neural crest cells destined to contribute to the trigem-
inal ganglia for αN-catenin protein. We observe αN-catenin in
these migratory neural crest cells during early and late stages of
trigeminal ganglia assembly as neural crest cells intermingle with
placode cells. αN-catenin localizes to the cytosol and neural crest
cell plasma membranes, coincident with membrane Cadherin-7
distribution, a cadherin that we have now shown, for the ﬁrst
time, to be present in migratory cranial neural crest cells. Inter-
estingly, we do not observe αN-catenin in placode cells, yet we do
note αN-catenin expression in migratory neural crest cells con-
tributing to the epibranchial ganglia (data not shown). This
suggests that αN-catenin function could be universal in facilitating
the condensation of neural crest cells and placode cells during
cranial ganglia formation.
The presence of αN-catenin in migratory neural crest cells
allowed us to posit that it plays a functional role in the later
assembly of neural crest-derived structures such as the cranial
ganglia. To address this hypothesis, we depleted or overexpressed
αN-catenin within migratory neural crest cells and examined
effects on cranial trigeminal ganglia morphology. Our earlier
studies indicated that short-term αN-catenin knock-down or
overexpression leads to an increase or decrease in the migratory
neural crest cell population, respectively (Jhingory et al., 2010). We
see similar results in this study upon altering αN-catenin in neural
crest cells as they are emerging from the dorsal neural tube and
during their migration. Our data indicate that perturbing αN-
catenin in migratory neural crest cells manifests as later disrup-
tions in trigeminal ganglion assembly. Other reports that have
examined the function of molecules expressed in neural crest or
placode cells during the formation of the cranial ganglia have used
similar techniques and observed comparable effects (Latta and
Golding, 2012; Shiau et al., 2008; Shiau and Bronner-Fraser, 2009;
Shigetani et al., 2008). Although it is possible that some of our
observed phenotypes could be attributed to effects on neural crest
cell EMT, given the timing of our electroporations, it is more likely
to be due to effects on migratory neural crest cells and the
function of αN-catenin therein. Because we observe αN-catenin
MO- and pCIG-αN-catenin/GFP-positive neural crest cells within
the condensing trigeminal ganglion, and aberrant ganglion assem-
bly, we conclude that our MO and expression constructs are still
Fig. 8. αN-catenin perturbation affects Cadherin-7 distribution and levels in the migratory neural crest cell population contributing to the trigeminal ganglia. (A,B)
Representative transverse sections taken at the axial level of the developing trigeminal ganglia after αN-catenin MO (A) or pCIG-αN-catenin (B) electroporation and re-
incubation of embryos to HH16, followed by Cadherin-7 (and GFP in (B)) immunohistochemistry. Arrows indicate regions of higher magniﬁcation within the ganglion, as
shown by (A0) for αN-catenin MO-positive cells, (A″) for αN-catenin MO-negative cells, (B0) for pCIG-αN-catenin-positive cells, and (B″) for pCIG-αN-catenin-negative cells.
Arrowheads in (A0) reveal diminished Cadherin-7 compared to Cadherin-7 in αN-catenin MO-negative cells (A″, arrowheads), or enhanced (B0) Cadherin-7 at the plasma
membrane in pCIG-αN-catenin-positive cells (B0) compared to Cadherin-7 in pCIG-αN-catenin-negative cells (B″). DAPI (blue) labels cell nuclei in all images. NT, neural tube;
TG, trigeminal ganglion. Scale bar in (A) is 13 mm and applicable to (B), while scale bar in (A0) is 3.3 mm and applicable to (A″,B0 ,B″).
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functional at later time points. These results suggest an important
role for αN-catenin in migratory neural crest cells as the trigem-
inal ganglia are forming.
To assess trigeminal ganglia morphology upon αN-catenin
knock-down in neural crest cells, we examined tissue sections
and whole embryos using antibodies to HNK-1 and Tubb3, labeling
neural crest cells and differentiated placodal neurons, respectively.
Remarkably, neural crest cell αN-catenin depletion affects trigem-
inal ganglion assembly on the treated side of the embryo. The
trigeminal ganglion does not form normally, with placode-derived
neurons appearing somewhat truncated and less condensed.
Although the number of placode cells is not changed, placode
cells are more dispersed throughout the ganglion. As such,
trigeminal ganglion assembly defects may relate to poor adhesion
and/or scaffolding provided by neural crest cells and/or aberrant
signaling between neural crest cells and placode cells upon αN-
catenin loss.
To corroborate our αN-catenin depletion data, we overex-
pressed αN-catenin within the migratory neural crest cell
population. In contrast to our knock-down data, the dorsal–ventral
distribution, and size of the migratory neural crest cell domain, is
reduced upon αN-catenin overexpression. Intriguingly, αN-catenin
overexpression within migratory neural crest cells decreases the
Islet-1-positive placodal cell population within the forming tri-
geminal ganglion. Tubb3 immunohistochemistry also reveals a
more dispersed and disordered ganglion upon ectopic expression
of αN-catenin. This phenotype is reminiscent of that observed
upon N-cadherin knock-down in placode cells (Shiau and Bronner-
Fraser, 2009). In these studies, even N-cadherin MO-negative
placode cells were affected, implying a non-cell autonomous
function for N-cadherin on placode cells during this process and
further highlighting the detrimental effects on cell–cell adhesion
that can ensue. The reduction in placode cell number suggests that
neural crest cells may be providing some cue that directly or
indirectly inﬂuences the number of placode cells contributing to
the trigeminal ganglion, thereby compromising ganglion assembly.
Additional experiments will be necessary to shed light on how
neural crest cell αN-catenin communicates with placode cells.
Given the presence of αN-catenin in neural crest cells contributing
to the epibranchial ganglia, it is possible that αN-catenin possesses
a general function in communication with placode cells during
cranial ganglia assembly. This may also hold true for the creation
of ganglia in the trunk, which arise from interactions between
neural crest cells.
αN-catenin regulation of cadherins: a mechanism underlying general
cranial ganglia assembly?
In our initial studies on αN-catenin, we noted that αN-catenin
perturbation modulates the levels of premigratory neural crest cell
cadherins and that this, at least partially, can explain the early neural
crest cell EMT/migration phenotypes we observe (Jhingory et al.,
2010). With our new data showing that αN-catenin and Cadherin-7
are expressed in migratory neural crest cells, we surmised that αN-
catenin played an important role in maintaining Cadherin-7-
mediated cell–cell contacts during neural crest cell migration and
potentially trigeminal ganglia assembly. Furthermore, the presence
of a trigeminal ganglion phenotype upon αN-catenin perturbation
led us to speculate that perhaps cadherin levels were altered in
neural crest cells expressing reduced or elevated levels of αN-
catenin. To this end, we examined Cadherin-7 levels in trigeminal
ganglia through immunohistochemistry in which αN-catenin was
either depleted (via the MO) or overexpressed. After αN-catenin
knock-down, we observe a reduction in Cadherin-7 in migratory
neural crest cells contributing to the trigeminal ganglion, including a
general decrease on the plasma membrane. These data indicate that
αN-catenin may function to maintain and/or stabilize membrane
Cadherin-7 in migratory neural crest cells, possibly through its
indirect interaction with the Cadherin-7 cytoplasmic tail via β-
catenin. Thus, the absence of αN-catenin may lead to increased
turnover of Cadherin-7. A role for αN-catenin in stabilizing cadherins
at the membrane has been reported previously in vitro (Hirano et al.,
1992; Watabe et al., 1994), and αN-catenin is likely performing a
similar function here in neural crest cells in vivo. A reduction in
Cadherin-7 may preclude effective neural crest cell–neural crest cell
and/or neural crest cell–placode cell communication, thereby poten-
tially favoring placode cell–placode cell interactions and disrupting
trigeminal ganglion assembly (Fig. 9).
In migratory neural crest cells within the trigeminal ganglion
overexpressing αN-catenin, Cadherin-7 levels are slightly elevated,
with protein localized to large puncta that appear to be membrane-
associated based on our confocal images. In this instance, ectopic
Fig. 9. Model depicting the role of αN-catenin in neural crest cells during the assembly of the trigeminal ganglion. (A) Neural crest cells (NCC) and placode cells intermingle
and coalesce to form the trigeminal ganglion. αN-catenin and Cadherin-7 (Cad7) are localized to neural crest cells, while placode cells express N-cadherin (N-cad).
(B) Depletion of αN-catenin expands the migratory neural crest cell domain, but these neural crest cells possess reduced levels of Cad7. This prevents the formation of an
effective scaffold for placode cells, leading to abnormalities in the formation of the trigeminal ganglion. (C) αN-catenin overexpression reduces the migratory neural crest cell
domain, and these neural crest cells possess increased levels of Cadherin-7 on the surface of neural crest cells. The decrease in neural crest cells in the trigeminal ganglion-
forming region may preclude effective interactions with placode cells. As in (B), the trigeminal ganglion is not assembled correctly. In (B) and (C), placode cell–placode cell
interactions may be favored over placode cell–neural crest cell interactions, further enforcing the aberrant assembly of the trigeminal ganglion. α, αN-catenin; β, β-catenin.
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expression of αN-catenin may stabilize Cadherin-7 at neural crest cell
plasma membranes, preventing its normal turnover. Within the
forming trigeminal ganglion, it is possible that those neural crest cells
that possess aberrant Cadherin-7 membrane distribution may not
coalesce correctly with placode cells due to (potentially) favored
neural crest cell–neural crest cell interactions over neural crest cell–
placode cell interactions. Placode cells may also associate preferentially
in this scenario, and altogether could lead to defects in trigeminal
ganglion assembly. Future work will discern whether this function for
αN-catenin in controlling Cadherin-7 levels is conserved in the
formation of other cranial and trunk ganglia.
Conclusion
Our results highlight a novel function for an adherens junction
component in migratory neural crest cells as they traverse the
embryo and eventually interact with placode cells to form the
trigeminal ganglia. αN-catenin plays a critical role in the formation
of early migratory neural crest cells from immotile precursors,
being down-regulated as neural crest cells undergo EMT. Proper
αN-catenin expression in motile cranial neural crest cells is then
later required to ensure that neural crest cells migrate appropri-
ately and effectively intermix and coalesce with epidermal placode
cells to form the trigeminal ganglia. These data further demon-
strate the multi-functionality of catenin proteins and may have
implications in the formation of other cranial ganglia, and general
tissue formation, during vertebrate development.
Materials and methods
Chick embryos
Fertilized chicken eggs (Gallus gallus) were obtained from B&E
(York Springs, PA) and Hy-Line North America, L.L.C. (Elizabeth-
town, PA), and incubated at 37 1C in humidiﬁed incubators.
Embryos were staged according to either the number of somite
pairs (somite stage) in early development or Hamburger–Hamilton
(HH) in later development (Hamburger and Hamilton, 1992).
In ovo unilateral electroporations
A 30 lissamine-labeled antisense αN-catenin morpholino (MO),
or a 5 base pair mismatch αN-catenin control MO, was used for
knock-down experiments at a concentration of 500 mM as
described previously (Jhingory et al., 2010). The pCIG-αN-catenin
or control (pCIG) vector (from (Jhingory et al., 2010)) was electro-
porated at a concentration of 2.5 μg/μl. Brieﬂy, MOs or expression
constructs were introduced into the early chick neural tube (HH9)
by ﬁne glass needles. After ﬁlling the neural tube, platinum
electrodes were placed on either side of the embryo, and two
25 V, 25 ms electric pulses were applied across the embryo in
order to electroporate the neural tube unilaterally, as in (Itasaki et
al., 1999; Jhingory et al., 2010). Eggs were re-sealed with tape and
paraﬁlm and re-incubated for 14–16 h, then imaged in ovo around
HH12 (prior to embryo turning) using a Zeiss AxioObserver.Z1
microscope in order to determine electroporation efﬁciency. After
imaging, eggs were re-sealed and re-incubated for the desired
time period prior to harvesting for further experimentation.
Whole-mount in situ hybridization
Whole-mount in situ hybridization for Sox10 was performed
as previously described in (Jhingory et al., 2010; Wilkinson, 1992;
Wilkinson and Nieto, 1993). Embryos were treated with Proteinase
K to increase accessibility of the probe to target RNA. Stained
embryos were imaged in 70% glycerol using a Zeiss SteREO
Discovery V8 microscope with a mounted camera. Transverse
sections were obtained by embedding embryos in gelatin and
cryostat-sectioning at 14 μm on a Leica Jung frigocut 2800E.
Sectioned images were acquired using a Zeiss AxioObserver.Z1
microscope and processed using Adobe Photoshop 9.0 (Adobe
Systems).
Immunohistochemistry and TUNEL assay
Immunohistochemical detection of TuJ1 (Covance, 1:200) was
performed in whole-mount following overnight ﬁxation in 4% PFA.
Immunohistochemical detection of HNK-1 (1:100), N-cadherin
(Developmental Studies Hybridoma Bank (DSHB) clone MNCD2,
1:200), Islet-1 (DSHB, clone 40.2D6, 1:200), Cadherin-7 (DSHB,
clone CCD7-1, 1:100), phospho-histone H3 (Millipore, 1:200) and
GFP (Invitrogen, A11122, 1:250) was performed on 14 mm trans-
verse sections following 4% PFA ﬁxation and gelatin embedding,
and αN-catenin (DSHB, clone NCAT2; 1:30-1:50) was carried out
on transverse sections following methanol ﬁxation and gelatin
embedding. All primary and secondary antibodies were diluted in
1X Phosphate-buffered salineþ0.1% Tween-20þ5% sheep serum
(PTW); in some instances, Cadherin-7 immunohistochemistry
was conducted using antibodies diluted in 1 Tris-buffered
salineþ0.1% Triton-Xþ5% fetal bovine serum (TBSTx). The follow-
ing secondary antibodies from Invitrogen were obtained and used
at 1:200-1:500 dilutions in PTW or TBSTx: Goat anti-mouse IgM
(HNK-1); goat anti-mouse IgG1 (Islet-1); goat or donkey anti-
rabbit IgG (phospho-histone H3); goat anti-rat IgG (N-cadherin
and αN-catenin); and goat anti-mouse IgG (Cadherin-7). TUNEL
assay (Roche, TMR red and ﬂuorescein) was performed on 4% PFA-
cryopreserved sections to detect apoptotic cells. Sections were
stained with 40,6-diamidino-2-phenylindole (DAPI) to mark the
cell nuclei. Embryos immunostained in whole-mount for Tubb3 or
section immunohistochemistry for cadherin and catenin proteins
were acquired using a Zeiss LSM710 confocal micoscope and
processed as described above.
Quantiﬁcation and statistical analysis
The dorsal–ventral domain of Sox10-positive migratory neural
crest cells was calculated by measuring the distance in at least
ﬁve serial sections (same magniﬁcation) through the assembling
trigeminal ganglia from a minimum of three embryos. Using the
“Ruler” tool and the “Record Measurement” function in Adobe
Photoshop, the distance along the dorsal–ventral axis, parallel to
the neural tube, was determined on the experimental and con-
tralateral side of each section (in a similar fashion as carried out in
(Fairchild and Gammill, 2013)). The average distance, standard
error of the mean, and fold change was then calculated across all
of the sections. The area occupied by HNK-1-positive cells was
quantiﬁed on the treated and contralateral control sides of
embryos in at least ﬁve serial sections (same magniﬁcation)
through the assembling trigeminal ganglia from a minimum of
four embryos. Using the “Lasso” tool in Adobe Photoshop, the
region containing HNK-1-positive migratory neural crest cells was
outlined on each section, and the “Record Measurement” function
was then employed to calculate arbitrary square pixel units of the
experimental and contralateral side of each section. These mea-
surements have been made in an analogous manner to those
described in (Latta and Golding, 2012; Shiau et al., 2008; Shiau and
Bronner-Fraser, 2009; Shigetani et al., 2008). Islet-1-, phospho-
histone H3- and TUNEL-positive cells were counted individually
following immunohistochemistry (or TUNEL assay) using the
Adobe Photoshop count tool and analyzed to compare cell
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numbers on the treated side versus the contralateral side in the
same section. At least ﬁve serial sections from a minimum of eight
embryos were examined. To analyze Cadherin-7 ﬂuorescence after
αN-catenin knock-down or overexpression, groups of two to ﬁve
MO- and GFP-positive or MO- and GFP-negative cells were
identiﬁed through their ﬂuorescence and DAPI staining. Two areas
each of positive and negative cells were selected for both MO and
GFP constructs. The “Outline Spline” tool of the Zeiss Axiovision
Release 4.8 software was used, as in (Wu et al., 2011), to calculate
the area of the selected cells and intensity value of Cadherin-7
expressed in the selected region of cells. The ratio of intensity to
area was then obtained for MO- or GFP-positive and MO- or GFP-
negative cells, and these ratios were averaged across at least four
sections from a minimum of three embryos. The fold change in
this ratio was then calculated to determine effects of αN-catenin
MO or overexpression on Cadherin-7 levels. For all measurements,
only those embryos having high electroporation efﬁciencies and
symmetric sections were chosen so as to not obscure the inter-
pretation of data. All results are reported as averages plus or minus
the standard error of the mean and were analyzed with a Student's
t test to establish statistical signiﬁcance, as in our prior work
(Jhingory et al., 2010; Wu and Taneyhill, 2012).
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